![Wen Jie Zhang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wen Jie Zhang
Vorsitzender bei
SHANGHAI HENLIUS BIOTECH, INC.
Profil
Wen Jie Zhang is Co-President & Co-CEO-Innovative Medicines at Shanghai Fosun Pharmaceutical (Group) Co., Ltd. since 2025.
Holds the position of President, Chief Executive Officer & Director at Shanghai Henlius Biopharmaceuticals Co., Ltd. since 2020.
Serves as Executive President & Co-Chief Executive Officer at Fosun Pharma Group Co. Ltd. Chairman of Shanghai Henlius Biotech, Inc. since 2023.
Chairman of Fosun Kite Biotechnology Co., Ltd. Director, Chief Executive & Financial Officer at Hengenix Biotech, Inc. Non-Independent Non-Executive Director at Gland Pharma Ltd. since 2024.
Education includes an undergraduate degree from Shandong University conferred in 1990 and an MBA from Yale School of Management.
Aktive Positionen von Wen Jie Zhang
| Unternehmen | Position | Beginn |
|---|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Vorsitzender | 30.11.2021 |
| GLAND PHARMA LIMITED | Direktor/Vorstandsmitglied | 30.08.2024 |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Präsident | 01.07.2023 |
Shanghai Henlius Biopharmaceuticals Co. , Ltd. | Vorstandsvorsitzender | - |
Hengenix Biotech, Inc.
 Hengenix Biotech, Inc. Aerospace & DefenseElectronic Technology Hengenix Biotech, Inc., operating as Hengennix, is a biotech-focused platform that provides news, breakthroughs, and insights in the biotechnology industry. The private company is based in Fremont. The American company features articles on company developments, the application of AI, translation, and innovations impacting medicine and human health. It offers multilingual content and covers topics such as advancements beyond medicine and the ongoing race for biotech progress. Hengennix is also associated with Linkflow, a team that improves business search engine rankings through personalized link-building strategies, content creation, and industry networking. The platform emphasizes intellectual property protection with a detailed DMCA policy for handling copyright infringement related to its content and services. The CEO of the company is Wen Jie Zhang. | Vorstandsvorsitzender | - |
Fosun Kite Biotechnology Co., Ltd.
 Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops immune cell therapies | Vorsitzender | - |
Fosun Pharma Group Co. Ltd. | Vorstandsvorsitzender | - |
Ausbildung von Wen Jie Zhang
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines, pharmaceuticals and medical equipment | Health Technology |
Gland Pharma Ltd.
 Gland Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical ingredients and injectable formulations | Health Technology |
Shandong University
 Shandong University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale School of Management
 Yale School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Henlius Biotech, Inc.
 Shanghai Henlius Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops immune cell therapies | Health Technology |
Shanghai Henlius Biopharmaceuticals Co. , Ltd. | |
Hengenix Biotech, Inc.
Hengenix Biotech, Inc. Aerospace & DefenseElectronic Technology Hengenix Biotech, Inc., operating as Hengennix, is a biotech-focused platform that provides news, breakthroughs, and insights in the biotechnology industry. The private company is based in Fremont. The American company features articles on company developments, the application of AI, translation, and innovations impacting medicine and human health. It offers multilingual content and covers topics such as advancements beyond medicine and the ongoing race for biotech progress. Hengennix is also associated with Linkflow, a team that improves business search engine rankings through personalized link-building strategies, content creation, and industry networking. The platform emphasizes intellectual property protection with a detailed DMCA policy for handling copyright infringement related to its content and services. The CEO of the company is Wen Jie Zhang. | Electronic Technology |
Fosun Pharma Group Co. Ltd. |
Wählen Sie MarketScreener 
